|
| Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs |
|
https://doi.org/10.18632/oncotarget.25968
Ting-Hui Wu, Nagla Karim, and Jeffrey A. Moscow
|
| 32404-32405 |
|
| Clinical utility of chromatin analysis |
|
https://doi.org/10.18632/oncotarget.25991
Andreas Kleppe, and HÃ¥vard E. Danielsen
|
| 32406-32407 |
|
| An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition |
|
https://doi.org/10.18632/oncotarget.25784
Ayesha T. Chawla, Agnes D. Cororaton, Michael O. Idowu, Priyadarshan K. Damle, Barbara Szomju, Keith C. Ellis, Bhaumik B. Patel, and Steven R. Grossman
|
| 32408-32418 |
|
| A novel molecular mechanism for a long noncoding RNA PCAT92 implicated in prostate cancer |
|
https://doi.org/10.18632/oncotarget.25940
Pushpinder Singh Bawa, Samathmika Ravi, Swagatika Paul, Bibha Chaudhary, and Subhashini Srinivasan
|
| 32419-32434 |
|
| Integrin α2β1 decelerates proliferation but promotes survival and invasion of prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25945
Marjaana Ojalill, Marjaana Parikainen, Pekka Rappu, Elina Aalto, Johanna Jokinen, Noora Virtanen, Elina Siljamäki, and Jyrki Heino
|
| 32435-32447 |
|
| “Two hits one stoneâ€; increased efficacy of cisplatinbased therapies by targeting PCNA’s role in both DNA repair and cellular signaling |
|
https://doi.org/10.18632/oncotarget.25963
Caroline Krogh Søgaard, Augun Blindheim, Lisa M. Røst, Voin Petrović, Anala Nepal, Siri Bachke, Nina-Beate Liabakk, Odrun A. Gederaas, Trond Viset, Carl-Jørgen Arum, Per Bruheim, and Marit Otterlei
|
| 32448-32465 |
|
| SPIN1 is a protooncogene and SPIN3 is a tumor suppressor in human seminoma |
|
https://doi.org/10.18632/oncotarget.25977
Damian Mikolaj Janecki, Marcin Sajek, Maciej Jerzy Smialek, Maciej Kotecki, Barbara Ginter-Matuszewska, Bogna Kuczynska, Anna Spik, Tomasz Kolanowski, Riko Kitazawa, Maciej Kurpisz, and Jadwiga Jaruzelska
|
| 32466-32477 |
|
| Zac1 regulates IL11 expression in osteoarthritis |
|
https://doi.org/10.18632/oncotarget.25980
Chun-Lin Kuo, Shu-Ting Liu, Yung-Lung Chang, Chia-Chun Wu, and Shih-Ming Huang
|
| 32478-32495 |
|
| Therapeutic targeting of Aurora A kinase in Philadelphia chromosomepositive ABL tyrosine kinase inhibitorresistant cells |
|
https://doi.org/10.18632/oncotarget.25985
Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, and Kazuma Ohyashiki
|
| 32496-32506 |
|
| miR193b and miR30c1* inhibit whereas miR5765p enhances melanoma cell invasion in vitro |
|
https://doi.org/10.18632/oncotarget.25986
Theresa Kordaß, Claudia E.M. Weber, David Eisel, Antonino A. Pane, Wolfram Osen, and Stefan B. Eichmüller
|
| 32507-32522 |
|
| Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases |
|
https://doi.org/10.18632/oncotarget.25992
Meaghan S. Dendy, Johannes M. Ludwig, Nima Kokabi, Stacey M. Stein, Jill Lacy, Howard S. Hochster, and Hyun S. Kim
|
| 32523-32533 |
|
| Approaches to the discovery of noninvasive urinary biomarkers of prostate cancer |
|
https://doi.org/10.18632/oncotarget.25946
Andrej Jedinak, Kevin R. Loughlin, and Marsha A. Moses
|
| 32534-32550 |
|
| Retraction: MicroRNA3715p targets SOX2 in gastric cancer |
|
https://doi.org/10.18632/oncotarget.26037
Yu-Ji Li, Ming Dong, Fan-Min Kong, Jian-Ping Zhou, Dong Liang, and Huan-Zhou Xue
|
| 32551-32551 |
